Xenon Pharmaceuticals (XENE) is trading at $62.76, up 49.6% intraday, and Relmada Therapeutics (RLMD) is at $7.17, up 61.1%. Both stocks surged sharply after major company-specific news that prompted investors to re-rate each name, driving elevated, idiosyncratic volatility. These are large moves for small-cap biotech names but appear stock-specific rather than broadly market-moving.
Xenon Pharmaceuticals (XENE) is trading at $62.76, up 49.6% intraday, and Relmada Therapeutics (RLMD) is at $7.17, up 61.1%. Both stocks surged sharply after major company-specific news that prompted investors to re-rate each name, driving elevated, idiosyncratic volatility. These are large moves for small-cap biotech names but appear stock-specific rather than broadly market-moving.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
strongly positive
Sentiment Score
0.70
Ticker Sentiment
